Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 70710-1700

This appears to be a table showing the results of a study or analysis of different analytes (possibly substances or drugs) in relation to different special populations (such as people with hepatic or renal impairment, advanced age, or specific genetic traits). The table lists the analytes and various impairments or conditions, and includes fold change and confidence interval data. The final number, 35, may refer to a change relative to a reference value.*

This text provides a list of drugs and their interaction with other drugs, along with some scientific data presented in the form of fold change and 90% CI values. However, the text is not complete or readable due to many errors.*

This appears to be a list of interacting drugs and their corresponding analytes, along with PK (pharmacokinetic) data including Cmax and AUC, and fold change with a 90% confidence interval. There are also some misspelled drug names. However, the data seems incomplete and difficult to interpret without proper context.*

This is a description of a medication known as Venlafaxine Hydrochloride Extended-Release capsules, which come in a package containing 90 capsules. The medication guide is to be dispensed separately. Each extended-release capsule contains venlafaxine hydrochloride equivalent to 37.5 mg of venlafaxine. The package is child-resistant, and the medication should be stored between 20°C and 25°C (66°F to 77°F) with excursions limited between 15°C to 30°C (59°F to 66°F). The medication is to be dispensed in a light container. Further information can be obtained from the medication guide by visiting a website or by calling a provided phone line. The medication is manufactured by Zydus Lifesciences Ltd in India and distributed by Zydus Pharmaceuticals in the USA.*

This is a description of Venlafaxine Hydrochloride Extended-Release Capsules, USP. Each capsule contains 75mg of Venlafaxine Hydrochloride. The recommended dosage and storage conditions are listed on the package insert. The medication guide is available online or by phone. The capsules are manufactured by Zydus Lifesciences Ltd. in India and distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ. It is important to keep this medication and other drugs out of reach of children.*

This product is an extended-release capsule containing venlafaxine hydrochloride USP equivalent to 150mg venlafaxine. The usual dosage should be checked in the package insert for complete prescribing information. The capsules should be stored at a temperature of 20°C to 25°C (66°F to 77°F) with excursions permitted between 3°F to 85°F. This package is child-resistant and should be dispensed in a light container. The medication guide is available at www.zydususa.com/medguides or by calling 1-877-993-8779. The product is manufactured by Zydus Lifesciences Ltd in Ahmedabad, India and distributed by Zydus Pharmaceuticals (USA) Inc.*